{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:36:34Z","timestamp":1773282994811,"version":"3.50.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T00:00:00Z","timestamp":1602115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T00:00:00Z","timestamp":1602115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100011091","name":"FOD Volksgezondheid, Veiligheid van de Voedselketen en Leefmilieu","doi-asserted-by":"publisher","award":["RF 14\/6287 DOSERESIST"],"award-info":[{"award-number":["RF 14\/6287 DOSERESIST"]}],"id":[{"id":"10.13039\/501100011091","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Knowledge of therapy-induced intestinal tract concentrations of antimicrobials allows for interpretation and prediction of antimicrobial resistance selection within the intestinal microbiota. This study describes the impact of three different doses of enrofloxacin (ENR) and two different administration routes on the intestinal concentration of ENR and on the fecal <jats:italic>Escherichia coli<\/jats:italic> populations in pigs. Enrofloxacin was administered on three consecutive days to four different treatment groups. The groups either received an oral bolus administration of ENR (conventional or half dose) or an intramuscular administration (conventional or double dose).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Quantitative analysis of fecal samples showed high ENR concentrations in all groups, ranging from 5.114\u2009\u00b1\u20091.272\u2009\u03bcg\/g up to 39.54\u2009\u00b1\u200910.43\u2009\u03bcg\/g at the end of the treatment period. In addition, analysis of the luminal intestinal content revealed an increase of ENR concentration from the proximal to the distal intestinal tract segments, with no significant effect of administration route. Fecal samples were also screened for resistance in <jats:italic>E. coli<\/jats:italic> isolates against ENR. Wild-type (MIC\u22640.125\u2009\u03bcg\/mL) and non-wild-type (0.125\u2009&lt;\u2009MIC\u22642\u2009\u03bcg\/mL) <jats:italic>E. coli<\/jats:italic> isolates were found at time 0\u2009h. At the end of treatment (3\u2009days) only non-wild-type isolates (MIC\u226532\u2009\u03bcg\/mL) were found.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In conclusion, the observed intestinal ENR concentrations in all groups showed to be both theoretically (based on pharmacokinetic and pharmacodynamic principles) and effectively (in vivo measurement) capable of significantly reducing the intestinal <jats:italic>E. coli<\/jats:italic> wild-type population.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12917-020-02608-9","type":"journal-article","created":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T13:03:14Z","timestamp":1602162194000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["The impact of therapeutic-dose induced intestinal enrofloxacin concentrations in healthy pigs on fecal Escherichia coli populations"],"prefix":"10.1186","volume":"16","author":[{"given":"Joren","family":"De Smet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filip","family":"Boyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siska","family":"Croubels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geertrui","family":"Rasschaert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Freddy","family":"Haesebrouck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Temmerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofie","family":"Rutjens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"De Backer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2512-4176","authenticated-orcid":false,"given":"Mathias","family":"Devreese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,8]]},"reference":[{"issue":"8","key":"2608_CR1","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1134\/S0003683813080024","volume":"49","author":"D Debabov","year":"2013","unstructured":"Debabov D. Antibiotic Resistance: Origins, Mechanisms, Approaches to Counter. Appl Biochem Micro+. 2013;49(8):665\u201371.","journal-title":"Appl Biochem Micro+"},{"issue":"2","key":"2608_CR2","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1021\/es901221x","volume":"44","author":"CW Knapp","year":"2010","unstructured":"Knapp CW, Dolfing J, Ehlert PAI, Graham DW. Evidence of increasing antibiotic resistance gene abundances in archived soils since 1940. Environ Sci Technol. 2010;44(2):580\u20137.","journal-title":"Environ Sci Technol"},{"issue":"5","key":"2608_CR3","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.mib.2009.08.001","volume":"12","author":"LB Rice","year":"2009","unstructured":"Rice LB. The clinical consequences of antimicrobial resistance. Curr Opin Microbiol. 2009;12(5):476\u201381.","journal-title":"Curr Opin Microbiol"},{"issue":"1","key":"2608_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0002-9629(15)41625-8","volume":"311","author":"FC Tenover","year":"1996","unstructured":"Tenover FC, McGowan JE Jr. Reasons for the emergence of antibiotic resistance. Am J Med Sci. 1996;311(1):9\u201316.","journal-title":"Am J Med Sci"},{"issue":"6","key":"2608_CR5","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1046\/j.1365-2672.2003.01937.x","volume":"94","author":"DP Blake","year":"2003","unstructured":"Blake DP, Humphry RW, Scott KP, Hillman K, Fenlon DR, Low JC. Influence of tetracycline exposure on tetracycline resistance and the carriage of tetracycline resistance genes within commensal Escherichia coli populations. J Appl Microbiol. 2003;94(6):1087\u201397.","journal-title":"J Appl Microbiol"},{"issue":"10","key":"2608_CR6","doi-asserted-by":"publisher","first-page":"4212","DOI":"10.1172\/JCI72333","volume":"124","author":"SR Modi","year":"2014","unstructured":"Modi SR, Collins JJ, Relman DA. Antibiotics and the gut microbiota. J Clin Invest. 2014;124(10):4212\u20138.","journal-title":"J Clin Invest"},{"issue":"10","key":"2608_CR7","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1016\/j.chemosphere.2010.11.067","volume":"82","author":"R Wei","year":"2011","unstructured":"Wei R, Ge F, Huang S, Chen M, Wang R. Occurrence of veterinary antibiotics in animal wastewater and surface water around farms in Jiangsu Province, China. Chemosphere. 2011;82(10):1408\u201314.","journal-title":"Chemosphere"},{"issue":"1","key":"2608_CR8","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/jac\/dkh262","volume":"54","author":"I Phillips","year":"2004","unstructured":"Phillips I, Casewell M, Cox T, de Groot B, Friis C, Jones R, et al. Does the use of antibiotics in food animals pose a risk to human health? A reply to critics. J Antimicrob Chemoth. 2004;54(1):276\u20138.","journal-title":"J Antimicrob Chemoth"},{"issue":"3","key":"2608_CR9","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1023\/A:1011959828103","volume":"15","author":"K Arimori","year":"1998","unstructured":"Arimori K, Nakano M. Drug exsorption from blood into the gastrointestinal tract. Pharm Res. 1998;15(3):371\u20136.","journal-title":"Pharm Res"},{"issue":"6","key":"2608_CR10","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.ijantimicag.2017.06.012","volume":"50","author":"J De Smet","year":"2017","unstructured":"De Smet J, Croubels S, De Backer P, Devreese M. Effect of administration route and dose alteration on sulfadiazine-trimethoprim plasma and intestinal concentrations in pigs. Int J Antimicrob Ag. 2017;50(6):707\u201314.","journal-title":"Int J Antimicrob Ag"},{"key":"2608_CR11","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s12917-016-0803-8","volume":"12","author":"LEJ Peeters","year":"2016","unstructured":"Peeters LEJ, Daeseleire E, Devreese M, Rasschaert G, Smet A, Dewulf J, et al. Residues of chlortetracycline, doxycycline and sulfadiazine-trimethoprim in intestinal content and feces of pigs due to cross-contamination of feed. BMC Vet Res. 2016;12:209.","journal-title":"BMC Vet Res"},{"key":"2608_CR12","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2165\/00003495-199958002-00013","volume":"58","author":"C Edlund","year":"1999","unstructured":"Edlund C, Nord CE. Effect of quinolones on intestinal ecology. Drugs. 1999;58:65\u201370.","journal-title":"Drugs."},{"key":"2608_CR13","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1186\/s12917-017-1260-8","volume":"13","author":"A R\u00f6mer","year":"2017","unstructured":"R\u00f6mer A, Scherz G, Reupke S, Mei\u00dfner J, Wallmann J, Kietzmann M, et al. Effects of intramuscularly administered enrofloxacin on the susceptibility of commensal intestinal Escherichia coli in pigs (sus scrofa domestica). BMC Vet Res. 2017;13:378.","journal-title":"BMC Vet Res"},{"issue":"3","key":"2608_CR14","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0034-5288(03)00112-7","volume":"75","author":"C Wiuff","year":"2003","unstructured":"Wiuff C, Lykkesfeldt J, Svendsen O, Aarestrup FM. The effects of oral and intramuscular administration and dose escalation of enrofloxacin on the selection of quinolone resistance among Salmonella and coliforms in pigs. Res Vet Sci. 2003;75(3):185\u201393.","journal-title":"Res Vet Sci"},{"issue":"1","key":"2608_CR15","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1089\/mdr.2014.0037","volume":"21","author":"B Callens","year":"2015","unstructured":"Callens B, Faes C, Maes D, Catry B, Boyen F, Francoys D, et al. Presence of antimicrobial resistance and antimicrobial use in sows are risk factors for antimicrobial resistance in their offspring. Microb Drug Resist. 2015;21(1):50\u20138.","journal-title":"Microb Drug Resist"},{"issue":"26","key":"2608_CR16","doi-asserted-by":"publisher","first-page":"4069","DOI":"10.2174\/1381612822666160303111031","volume":"22","author":"E Gasthuys","year":"2016","unstructured":"Gasthuys E, Vandecasteele T, De Bruyne P, Walle JV, De Backer P, Cornillie P, et al. The potential use of piglets as human pediatric surrogate for preclinical pharmacokinetic and Pharmacodynamic drug testing. Curr Pharm Design. 2016;22(26):4069\u201385.","journal-title":"Curr Pharm Design"},{"key":"2608_CR17","first-page":"GL49","volume-title":"Studies to Evaluate the Metabolism and Residue Kinetics of Veterinary Drugs in Food Producing Animals: Validation of Analytical Methods Used in Residue Depletion Studies","author":"VICH","year":"2016","unstructured":"VICH. Studies to Evaluate the Metabolism and Residue Kinetics of Veterinary Drugs in Food Producing Animals: Validation of Analytical Methods Used in Residue Depletion Studies; 2016. p. GL49."},{"key":"2608_CR18","first-page":"8","volume":"221","author":"IC Directive","year":"2002","unstructured":"Directive IC. 96\/23\/EC concerning the performance of analytical methods and the interpretation of results. Off J Eur Communities. 2002;221:8\u201336.","journal-title":"Off J Eur Communities"},{"issue":"1","key":"2608_CR19","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s12917-014-0289-1","volume":"10","author":"M Devreese","year":"2014","unstructured":"Devreese M, Antonissen G, De Baere S, De Backer P, Croubels S. Effect of administration route and dose escalation on plasma and intestinal concentrations of enrofloxacin and ciprofloxacin in broiler chickens. BMC Vet Res. 2014;10(1):289.","journal-title":"BMC Vet Res"},{"issue":"5","key":"2608_CR20","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/j.1600-0773.1997.tb01967.x","volume":"80","author":"P Nielsen","year":"1997","unstructured":"Nielsen P, GyrdHansen N. Bioavailability of enrofloxacin after oral administration to fed and fasted pigs. Pharmacol Toxicol. 1997;80(5):246\u201350.","journal-title":"Pharmacol Toxicol"},{"issue":"10","key":"2608_CR21","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1093\/jac\/dks224","volume":"67","author":"L Jakobsen","year":"2012","unstructured":"Jakobsen L, Cattoir V, Jensen KS, Hammerum AM, Nordmann P, Frimodt-Moller N. Impact of low-level fluoroquinolone resistance genes qnrA1, qnrB19 and qnrS1 on ciprofloxacin treatment of isogenic Escherichia coli strains in a murine urinary tract infection model. J Antimicrob Chemother. 2012;67(10):2438\u201344.","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"2608_CR22","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.ijantimicag.2013.07.008","volume":"42","author":"AA Ferran","year":"2013","unstructured":"Ferran AA, Bibbal D, Pellet T, Laurentie M, Gicquel-Bruneau M, Sanders P, et al. Pharmacokinetic\/pharmacodynamic assessment of the effects of parenteral administration of a fluoroquinolone on the intestinal microbiota: comparison of bactericidal activity at the gut versus the systemic level in a pig model. Int J Antimicrob Agents. 2013;42(5):429\u201335.","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"2608_CR23","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1046\/j.1365-2885.2002.00430.x","volume":"25","author":"C Wiuff","year":"2002","unstructured":"Wiuff C, Lykkesfeldt J, Aarestrup FM, Svendsen O. Distribution of enrofloxacin in intestinal tissue and contents of healthy pigs after oral and intramuscular administrations. J Vet Pharmacol Ther. 2002;25(5):335\u201342.","journal-title":"J Vet Pharmacol Ther"},{"issue":"3","key":"2608_CR24","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.etap.2008.04.004","volume":"26","author":"XJ Zhou","year":"2008","unstructured":"Zhou XJ, Chen CX, Yue L, Sun YX, Ding HZ, Liu YH. Excretion of enrofloxacin in pigs and its effect on ecological environment. Environ Toxicol Phar. 2008;26(3):272\u20137.","journal-title":"Environ Toxicol Phar"},{"key":"2608_CR25","first-page":"290","volume-title":"Antimicrobial therapy in veterinary medicine, Sulfonomides, Diaminopyrimidines and their combinations","author":"JF Prescott","year":"2000","unstructured":"Prescott JF, Baggott JD, Walker RD. Antimicrobial therapy in veterinary medicine, Sulfonomides, Diaminopyrimidines and their combinations. Ames,Iowa: Iowa State University press; 2000. p. 290\u2013314."},{"issue":"7","key":"2608_CR26","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1038\/sj.bjp.0702703","volume":"127","author":"S Dautrey","year":"1999","unstructured":"Dautrey S, Felice K, Petiet A, Lacour B, Carbon C, Farinotti R. Active intestinal elimination of ciprofloxacin in rats: modulation by different substrates. Br J Pharmacol. 1999;127(7):1728\u201334.","journal-title":"Br J Pharmacol"},{"issue":"1\u20132","key":"2608_CR27","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ijpharm.2006.02.004","volume":"313","author":"S Zakelj","year":"2006","unstructured":"Zakelj S, Sturm K, Kristl A. Ciprofloxacin permeability and its active secretion through rat small intestine in vitro. Int J Pharm. 2006;313(1\u20132):175\u201380.","journal-title":"Int J Pharm"},{"issue":"2","key":"2608_CR28","first-page":"496","volume":"269","author":"NM Griffiths","year":"1994","unstructured":"Griffiths NM, Hirst BH, Simmons NL. Active intestinal secretion of the fluoroquinolone antibacterials ciprofloxacin, norfloxacin and pefloxacin; a common secretory pathway? J Pharmacol Exp Ther. 1994;269(2):496\u2013502.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"2608_CR29","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.tvjl.2005.07.010","volume":"172","author":"M Martinez","year":"2006","unstructured":"Martinez M, McDermott P, Walker R. Pharmacology of the fluoroquinolones: a perspective for the use in domestic animals. Vet J. 2006;172(1):10\u201328.","journal-title":"Vet J"},{"issue":"2","key":"2608_CR30","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0003-2670(01)00997-7","volume":"437","author":"J Barbosa","year":"2001","unstructured":"Barbosa J, Barron D, Jimenez-Lozano E, Sanz-Nebot V. Comparison between capillary electrophoresis, liquid chromatography, potentiometric and spectrophotometric techniques for evaluation of pK(a) values of zwitterionic drugs in acetonitrile-water mixtures. Anal Chim Acta. 2001;437(2):309\u201321.","journal-title":"Anal Chim Acta"},{"issue":"Suppl 3","key":"2608_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/1120009X.2004.11782371","volume":"16","author":"JM Blondeau","year":"2004","unstructured":"Blondeau JM, Hansen G, Metzler K, Hedlin P. The role of PK\/PD parameters to avoid selection and increase of resistance: mutant prevention concentration. J Chemother. 2004;16(Suppl 3):1\u201319.","journal-title":"J Chemother"},{"issue":"10","key":"2608_CR32","doi-asserted-by":"publisher","first-page":"233s","DOI":"10.1592\/phco.21.16.233S.33992","volume":"21","author":"KA Rodvold","year":"2001","unstructured":"Rodvold KA, Neuhauser M. Pharmacokinetics and pharmacodynamics of fluoroquinolones. Pharmacotherapy. 2001;21(10):233s\u201352s.","journal-title":"Pharmacotherapy"},{"issue":"5","key":"2608_CR33","first-page":"1029","volume":"34","author":"DL Huseby","year":"2017","unstructured":"Huseby DL, Pietsch F, Brandis G, Garoff L, Tegehall A, Hughes D. Mutation supply and relative fitness shape the genotypes of ciprofloxacin-resistant Escherichia coli. Mol Biol Evol. 2017;34(5):1029\u201339.","journal-title":"Mol Biol Evol"},{"issue":"10","key":"2608_CR34","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1128\/AAC.40.10.2380","volume":"40","author":"MJ Everett","year":"1996","unstructured":"Everett MJ, Jin YF, Ricci V, Piddock LJ. Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals. Antimicrob Agents Chemother. 1996;40(10):2380\u20136.","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"2608_CR35","first-page":"853","volume":"51","author":"SL Checkley","year":"2010","unstructured":"Checkley SL, Campbell JR, Chirino-Trejo M, Janzen ED, Waldner CL. Associations between antimicrobial use and the prevalence of antimicrobial resistance in fecal Escherichia coli from feedlot cattle in western Canada. The Canadian veterinary journal = La revue veterinaire canadienne. 2010;51(8):853\u201361.","journal-title":"The Canadian veterinary journal = La revue veterinaire canadienne"},{"issue":"3","key":"2608_CR36","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.prevetmed.2008.10.002","volume":"88","author":"C Varga","year":"2009","unstructured":"Varga C, Rajic A, McFall ME, Reid-Smith RJ, Deckert AE, Checkley SL, et al. Associations between reported on-farm antimicrobial use practices and observed antimicrobial resistance in generic fecal Escherichia coli isolated from Alberta finishing swine farms. Prev Vet Med. 2009;88(3):185\u201392.","journal-title":"Prev Vet Med"},{"issue":"15","key":"2608_CR37","doi-asserted-by":"publisher","first-page":"4785","DOI":"10.1128\/AEM.00252-07","volume":"73","author":"D Bibbal","year":"2007","unstructured":"Bibbal D, Dupouy V, Ferre JP, Toutain PL, Fayet O, Prere MF, et al. Impact of three ampicillin dosage regimens on selection of ampicillin resistance in Enterobacteriaceae and excretion of Bla (TEM) genes in swine feces. Appl Environ Microb. 2007;73(15):4785\u201390.","journal-title":"Appl Environ Microb"},{"issue":"5","key":"2608_CR38","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1586\/14787210.6.5.733","volume":"6","author":"FM Aarestrup","year":"2008","unstructured":"Aarestrup FM, Wegener HC, Collignon P. Resistance in bacteria of the food chain: epidemiology and control strategies. Expert Rev Anti-Infect Ther. 2008;6(5):733\u201350.","journal-title":"Expert Rev Anti-Infect Ther"},{"issue":"5","key":"2608_CR39","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1128\/IAI.56.5.1030-1035.1988","volume":"56","author":"EA Wadolkowski","year":"1988","unstructured":"Wadolkowski EA, Laux DC, Cohen PS. Colonization of the streptomycin-treated mouse large-intestine by a human fecal Escherichia-Coli strain - role of growth in mucus. Infect Immun. 1988;56(5):1030\u20135.","journal-title":"Infect Immun"},{"key":"2608_CR40","doi-asserted-by":"publisher","first-page":"8292","DOI":"10.1038\/ncomms9292","volume":"6","author":"H Li","year":"2015","unstructured":"Li H, Limenitakis JP, Fuhrer T, Geuking MB, Lawson MA, Wyss M, et al. The outer mucus layer hosts a distinct intestinal microbial niche. Nat Commun. 2015;6:8292.","journal-title":"Nat Commun"},{"key":"2608_CR41","doi-asserted-by":"publisher","first-page":"3216","DOI":"10.1099\/mic.0.040618-0","volume":"156","author":"C Jernberg","year":"2010","unstructured":"Jernberg C, Lofmark S, Edlund C, Jansson JK. Long-term impacts of antibiotic exposure on the human intestinal microbiota. Microbiol-Sgm. 2010;156:3216\u201323.","journal-title":"Microbiol-Sgm."},{"issue":"5","key":"2608_CR42","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1111\/j.1574-6976.2011.00289.x","volume":"35","author":"DI Andersson","year":"2011","unstructured":"Andersson DI, Hughes D. Persistence of antibiotic resistance in bacterial populations. FEMS Microbiol Rev. 2011;35(5):901\u201311.","journal-title":"FEMS Microbiol Rev"},{"key":"2608_CR43","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.aca.2012.10.027","volume":"756","author":"S De Baere","year":"2012","unstructured":"De Baere S, Osselaere A, Devreese M, Vanhaecke L, De Backer P, Croubels S. Development of a liquid-chromatography tandem mass spectrometry and ultra-high-performance liquid chromatography high-resolution mass spectrometry method for the quantitative determination of zearalenone and its major metabolites in chicken and pig plasma. Anal Chim Acta. 2012;756:37\u201348.","journal-title":"Anal Chim Acta"},{"key":"2608_CR44","unstructured":"Scott Sutton. Accuracy of Plate Counts. J Validation Technol. 2011. http:\/\/www.microbiol.org\/resources\/monographswhite-papers\/counting-colonies\/."},{"issue":"5","key":"2608_CR45","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1111\/jam.13561","volume":"123","author":"LEJ Peeters","year":"2017","unstructured":"Peeters LEJ, De Mulder T, Van Coillie E, Huygens J, Smet A, Daeseleire E, et al. Selection and transfer of an IncI1-tet(a) plasmid of Escherichia coli in an exvivo model of the porcine caecum at doxycycline concentrations caused by crosscontaminated feed. J Appl Microbiol. 2017;123(5):1312\u201320.","journal-title":"J Appl Microbiol"},{"key":"2608_CR46","unstructured":"Liofilchem. Quantitative assay for determining the Minimum Inhibitory Concentration (MIC), Accessed 05\/02\/2018 2018 [Available from: http:\/\/www.liofilchem.net\/pdf\/mic\/micTS.pdf."},{"issue":"7","key":"2608_CR47","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.1128\/AAC.00203-13","volume":"57","author":"I Lysnyansky","year":"2013","unstructured":"Lysnyansky I, Gerchman I, Mikula I, Gobbo F, Catania S, Levisohn S. Molecular characterization of acquired Enrofloxacin resistance in mycoplasma synoviae field isolates. Antimicrob Agents Chemother. 2013;57(7):3072\u20137.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"2608_CR48","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s00253-011-3557-z","volume":"92","author":"F Collin","year":"2011","unstructured":"Collin F, Karkare S, Maxwell A. Exploiting bacterial DNA gyrase as a drug target: current state and perspectives. Appl Microbiol Biot. 2011;92(3):479\u201397.","journal-title":"Appl Microbiol Biot"},{"key":"2608_CR49","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.3389\/fmicb.2015.01355","volume":"6","author":"A Johnning","year":"2015","unstructured":"Johnning A, Kristiansson E, Fick J, Weijdegard B, Larsson DGJ. Resistance mutations in gyrA and parC are common in Escherichia communities of both Fluoroquinolone-polluted and uncontaminated aquatic environments. Front Microbiol. 2015;6:1355.","journal-title":"Front Microbiol"},{"issue":"8","key":"2608_CR50","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1128\/AAC.01686-07","volume":"52","author":"JH Liu","year":"2008","unstructured":"Liu JH, Deng YT, Zeng ZL, Gao JH, Chen L, Arakawa Y, et al. Coprevalence of plasmid-mediated quinolone resistance determinants QepA, Qnr, and AAC (6 ')-Ib-cr among 16S rRNA methylase RmtB-producing Escherichia coli isolates from pigs. Antimicrob Agents Chemother. 2008;52(8):2992\u20133.","journal-title":"Antimicrob Agents Chemother"},{"key":"2608_CR51","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1093\/jac\/dkx104","volume":"72","author":"I Chantziaras","year":"2017","unstructured":"Chantziaras I, Smet A, Haesebrouck F, Boyen F, Dewulf J. Studying the effect of administration route and treatment dose on the selection of enrofloxacin resistance in commensal Escherichia coli in broilers. J Antimicrob Chemother. 2017;72:1991.","journal-title":"J Antimicrob Chemother"},{"key":"2608_CR52","unstructured":"https:\/\/www.ncbi.nlm.nih.gov\/gene\/946614. Accessed 28 Jan 2019."},{"key":"2608_CR53","unstructured":"https:\/\/www.ncbi.nlm.nih.gov\/gene\/947499. Accessed 28 Jan 2019."},{"issue":"5","key":"2608_CR54","first-page":"346","volume":"37","author":"M Dailloux","year":"1989","unstructured":"Dailloux M, Petitpain N, Henry C, Weber M. In vitro determination of the sensitivity of mycobacteria to fluoroquinolones. Pathologie-biologie. 1989;37(5):346\u20139.","journal-title":"Pathologie-biologie."}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-020-02608-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12917-020-02608-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-020-02608-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T00:07:24Z","timestamp":1633651644000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcvetres.biomedcentral.com\/articles\/10.1186\/s12917-020-02608-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,8]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2608"],"URL":"https:\/\/doi.org\/10.1186\/s12917-020-02608-9","relation":{},"ISSN":["1746-6148"],"issn-type":[{"value":"1746-6148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,8]]},"assertion":[{"value":"17 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The animal experiment was approved by the Ethical Committee of the Faculties of Veterinary Medicine and Bioscience Engineering of Ghent University (case number EC 2015\u201316).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.Members of journal editorial board: Prof. Dr. Mathias Devreese, Dr. Filip Boyen.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"382"}}